These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8829205)
1. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats. Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205 [TBL] [Abstract][Full Text] [Related]
2. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876 [TBL] [Abstract][Full Text] [Related]
3. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats]. Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795 [TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat. Crespi F; Keane PE; Morre M Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis. Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565 [TBL] [Abstract][Full Text] [Related]
6. A thyrotropin releasing hormone analog, DN-1417, increases endogenous dopamine release from slices of rat striatum and nucleus accumbens. Yamada S; Kojima H; Tsutsumi T; Nakamura J; Anraku S; Nishi S; Inanaga K Kurume Med J; 1983; 30 Suppl():S29-35. PubMed ID: 6434800 [No Abstract] [Full Text] [Related]
7. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169 [TBL] [Abstract][Full Text] [Related]
8. Effect of vagotomy on hyperactivity and increased dopamine turnover induced by intraperitoneal administration of thyrotropin-releasing hormone. Ogawa N; Asanuma M; Kondo Y; Hirata H; Nakayama N; Mori A Brain Res; 1994 Jan; 633(1-2):167-70. PubMed ID: 8137153 [TBL] [Abstract][Full Text] [Related]
9. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495 [TBL] [Abstract][Full Text] [Related]
10. Permeability of NS-3, a thyrotropin-releasing hormone analogue, into the brain after its systemic administration in rats: a microdialysis study. Itoh Y; Sugimoto T; Ukai Y; Morino A; Kimura K J Pharm Pharmacol; 1995 Oct; 47(10):833-6. PubMed ID: 8583352 [TBL] [Abstract][Full Text] [Related]
11. TRH injected into the nucleus accumbens shell releases dopamine and reduces feeding motivation in rats. Puga L; Alcántara-Alonso V; Coffeen U; Jaimes O; de Gortari P Behav Brain Res; 2016 Jun; 306():128-36. PubMed ID: 27006143 [TBL] [Abstract][Full Text] [Related]
12. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis. Hernandez L; Auerbach S; Hoebel BG Life Sci; 1988; 42(18):1713-23. PubMed ID: 2452334 [TBL] [Abstract][Full Text] [Related]
13. Effect of NS-3, a thyrotropin-releasing hormone analog, on in vivo acetylcholine release in rat brain: regional differences and its sites of action. Itoh Y; Ogasawara T; Mushiroi T; yamazaki A; Ukai Y; Kimura K J Pharmacol Exp Ther; 1994 Nov; 271(2):884-90. PubMed ID: 7965809 [TBL] [Abstract][Full Text] [Related]
14. Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats. Shinozuka K; Shimoura K; Hattori K Gen Pharmacol; 1997 Feb; 28(2):209-14. PubMed ID: 9013196 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens. Pepper JP; Baumann MH; Ayestas M; Rothman RB Brain Res Mol Brain Res; 2001 Mar; 87(2):184-9. PubMed ID: 11245920 [TBL] [Abstract][Full Text] [Related]
16. Protein kinases are involved in prolonged acetylcholine release from rat hippocampus induced by thyrotropin-releasing hormone analogue NS-3. Oka M; Itoh Y; Ukai Y; Yoshikuni Y; Kimura K J Neurochem; 1996 May; 66(5):1889-93. PubMed ID: 8780015 [TBL] [Abstract][Full Text] [Related]
17. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone. Agarwal RA; Rastogi RB; Singhal RL Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone. Keller HH; Bartholini G; Pletscher A Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412 [No Abstract] [Full Text] [Related]
19. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone. Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267 [No Abstract] [Full Text] [Related]
20. Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Dringenberg HC; de Souza-Silva MA; Schwarting RK; Huston JP Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):423-9. PubMed ID: 9826064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]